{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:59:21Z","timestamp":1787731161835,"version":"build-2784847793"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005042","name":"Cliniques Universitaires Saint-Luc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.tracli.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T13:33:44Z","timestamp":1689255224000},"page":"402-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["O-negative blood shortage management in a university hospital: Impact of transfusing RhD-positive red blood cells to RhD-negative patients"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0878-8798","authenticated-orcid":false,"given":"Urszula","family":"Luyten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Peeraer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pirlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssra","family":"Khaouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Streel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-4129","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Deneys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2023.06.007_b0005","first-page":"7","article-title":"Storm on O negative blood: \u201ccollateral damage\u201d of patient blood management?","volume":"141","author":"Deneys","year":"2022","journal-title":"Louvain M\u00e9dical"},{"key":"10.1016\/j.tracli.2023.06.007_b0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tracli.2010.09.166","article-title":"Choix des concentr\u00e9s \u00e9rythrocytaires d\u00e9livr\u00e9s par les d\u00e9p\u00f4ts et s\u00e9curit\u00e9 transfusionnelle immunologique","volume":"17","author":"Py","year":"2010","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2023.06.007_b0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/vox.12492","article-title":"Group O RBCs: where is universal donor blood being used","volume":"112","author":"Barty","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.06.007_b0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/vox.13357","article-title":"Use of O RhD-negative red blood cells: A nationwide, prospective audit","volume":"117","author":"Ilmakunnas","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.06.007_b0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/trf.14012","article-title":"A national review of the clinical use of group O D\u2013 red blood cell units","volume":"57","author":"Hirani","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0030","first-page":"49","article-title":"Innovations 2021 en biologie h\u00e9matologique","volume":"141","author":"Deneys","year":"2022","journal-title":"Louvain M\u00e9dical"},{"key":"10.1016\/j.tracli.2023.06.007_b0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/trf.12925","article-title":"A case for stocking O D+ red blood cells in emergency room trauma bays","volume":"55","author":"Meyer","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0040","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S2352-3026(17)30051-0","article-title":"Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study","volume":"4","author":"Selleng","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.tracli.2023.06.007_b0045","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/bloodadvances.2021004395","article-title":"Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage","volume":"5","author":"Uter","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2023.06.007_b0050","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/trf.14547","article-title":"O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS study","volume":"58","author":"Dunbar","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tmrv.2006.08.003","article-title":"Blood Group Antibodies and Their Significance in Transfusion Medicine","volume":"21","author":"Poole","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2023.06.007_b0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V95.2.375","article-title":"The Rh blood group system: a review","volume":"95","author":"Avent","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2023.06.007_b0065","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2018-08-833962","article-title":"Transfusion-related red blood cell alloantibodies: induction and consequences","volume":"133","author":"Tormey","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2023.06.007_b0070","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/vox.13232","article-title":"Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: A systematic review and meta-analysis","volume":"117","author":"Ji","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.06.007_b0075","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/trf.13999","article-title":"Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions","volume":"57","author":"Arora","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0080","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/trf.12639","article-title":"Immunosuppressants and alloimmunization against red blood cell transfusions","volume":"54","author":"Zalpuri","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.21307\/immunohematology-2019-133","article-title":"Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen","volume":"29","author":"Seager","year":"2013","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2023.06.007_b0090","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1537-2995.2008.01700.x","article-title":"Prospective evaluation of a transfusion policy of D+ red blood cells into D\u2212 patients","volume":"48","author":"Gonzalez-Porras","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0095","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3324\/haematol.2020.270546","article-title":"Red cell transfusion and alloimmunization in sickle cell disease","volume":"106","author":"Linder","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2023.06.007_b0100","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3324\/haematol.2017.175752","article-title":"Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome","volume":"102","author":"Singhal","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2023.06.007_b0105","first-page":"4","article-title":"Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review","volume":"17","author":"Franchini","year":"2019","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2023.06.007_b0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12455","article-title":"Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes","volume":"112","author":"Lin","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.06.007_b0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.tracli.2023.06.007_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100588","article-title":"Challenges of blood transfusions in \u03b2-thalassemia","volume":"37","author":"Shah","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.tracli.2023.06.007_b0125","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/bjh.14307","article-title":"Red cell alloimmunisation in patients with different types of infections","volume":"175","author":"Evers","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2023.06.007_b0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjh.13781","article-title":"Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization","volume":"174","author":"Ryder","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2023.06.007_b0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/vox.12914","article-title":"Red-blood-cell alloimmunization and prophylactic antigen matching for transfusion in patients with warm autoantibodies","volume":"115","author":"Delaney","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.06.007_b0140","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1111\/trf.16495","article-title":"Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products","volume":"61","author":"Yazer","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.21307\/immunohematology-2019-110","article-title":"Transfusion of D+ red blood cells to D- individuals in trauma situations","volume":"30","author":"Tchakarov","year":"2014","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2023.06.007_b0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000485388","article-title":"Unmatched Type O RhD+ Red Blood Cells in Multiple Injured Patients","volume":"45","author":"Flommersfeld","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2023.06.007_b0155","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/j.1537-2995.2007.01446.x","article-title":"Detection of anti-D in D\u2013 recipients transfused with D+ red blood cells","volume":"47","author":"Yazer","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/trf.13977","article-title":"Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study","volume":"57","author":"Delaney","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2023.06.007_b0170","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1111\/trf.12802","article-title":"The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine","volume":"54","author":"Callum","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2023.06.007_b0175","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/MPH.0000000000000241","article-title":"Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease","volume":"37","author":"Ipe","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.tracli.2023.06.007_b0180","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2023.06.007_b0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5858\/arpa.2015-0444-RS","article-title":"The Direct Antiglobulin Test: Indications, Interpretation, and Pitfalls","volume":"141","author":"Parker","year":"2017","journal-title":"Arch Pathol Lab Med"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782023000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782023000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:40:50Z","timestamp":1761129650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782023000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1246782023000721"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2023.06.007","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"O-negative blood shortage management in a university hospital: Impact of transfusing RhD-positive red blood cells to RhD-negative patients","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}